FSCNX
Price
$18.15
Change
+$0.04 (+0.22%)
Updated
Jul 31 closing price
Net Assets
5.6B
RLBAX
Price
$39.97
Change
+$0.07 (+0.18%)
Updated
Jul 31 closing price
Net Assets
288.09B
Interact to see
Advertisement

FSCNX vs RLBAX

FSCNX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
FSCNX vs. RLBAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSCNX is a Buy and RLBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 288B vs. FSCNX (5.6B). RLBAX pays higher dividends than FSCNX: RLBAX (1.13) vs FSCNX (0.90). FSCNX was incepted earlier than RLBAX: FSCNX (19 years) vs RLBAX (24 years). FSCNX (1.70) is less costly to investors than RLBAX (1.32). RLBAX is a more actively managed with annual turnover of: 50.00 vs. FSCNX (29.00). FSCNX has a lower initial minimum investment than RLBAX: FSCNX (0) vs RLBAX (250). FSCNX annual gain was more profitable for investors over the last year : 11.88 vs. RLBAX (10.43). RLBAX return over 5 years is better than : 28.18 vs. FSCNX (19.98).
FSCNXRLBAXFSCNX / RLBAX
Total Expense Ratio1.671.32127%
Annual Report Gross Expense Ratio1.701.32129%
Fund Existence19 years24 years-
Gain YTD8.4237.908107%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.6B288B2%
Annual Yield % from dividends0.901.1380%
Returns for 1 year11.8810.43114%
Returns for 3 years33.3835.4594%
Returns for 5 years19.9828.1871%
Returns for 10 years73.9473.40101%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OSRH0.450.02
+4.19%
OSR Health Inc
QLYS144.753.04
+2.15%
Qualys
SE106.740.50
+0.47%
Sea Limited
CRTO21.82-0.12
-0.55%
Criteo SA
SLN10.49-1.13
-9.72%
Silence Therapeutics Plc